Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | DPP4 | P27487 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | NAAA | Q02083 | 2/20 | 0.31 |
| ▸ | CTSL | P07711 | 1/20 | 0.31 |
| ▸ | CTSB | P07858 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19974730 | 0.80 | EPHX1 (0.38) | NPC1PKMEPHX2RAB9ASMN1; SMN2 | |
| SCHEMBL19982888 | 0.76 | EPHX1 (0.53) | NPC1RAB9AEPHX1CTSLCTSB | |
| SCHEMBL22132035 | 0.70 | EPHX1 (0.44) | NPC1EPHX2SMN1; SMN2KMT2AMEN1 | |
| SCHEMBL19982712 | 0.69 | EPHX1 (0.33) | NPC1PKMEPHX2RAB9ASMN1; SMN2 | |
| SCHEMBL23975247 | 0.66 | NAAA (0.57) | NPC1PKMEPHX2RAB9ASMN1; SMN2 | |
| SCHEMBL14407371 | 0.65 | EPHX1 (0.40) | NPC1PKMEPHX2RAB9ASMN1; SMN2 | |
| SCHEMBL22131907 | 0.65 | MAPK1 (0.40) | SMN1; SMN2EPHX1 | |
| SCHEMBL1259849 | 0.64 | NPC1 (0.52) | NPC1EPHX1NAAA | |
| SCHEMBL19974839 | 0.64 | EPHX1 (0.39) | NPC1PKMEPHX2RAB9ASMN1; SMN2 | |
| SCHEMBL23975364 | 0.64 | NAAA (0.62) | NPC1PKMEPHX2RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018050631-A1 | ANTIVIRAL COMPOUNDS | HAPLOGEN GMBH (AT) | 2018-03-22 | — | — | WO | disclosed |